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Attenuated Total Reflectance 
Fourier Transform Infrared 
Spectroscopy: An analytical 
technique to understand 
therapeutic responses at the 
molecular level
Sushma Kalmodia1,2, Sowmya Parameswaran3, Wenrong Yang2, Colin J. Barrow2 & 
Subramanian Krishnakumar1
Rapid monitoring of the response to treatment in cancer patients is essential to predict the outcome 
of the therapeutic regimen early in the course of the treatment. The conventional methods are 
laborious, time-consuming, subjective and lack the ability to study different biomolecules and their 
interactions, simultaneously. Since; mechanisms of cancer and its response to therapy is dependent 
on molecular interactions and not on single biomolecules, an assay capable of studying molecular 
interactions as a whole, is preferred. Fourier Transform Infrared (FTIR) spectroscopy has become a 
popular technique in the field of cancer therapy with an ability to elucidate molecular interactions. 
The aim of this study, was to explore the utility of the FTIR technique along with multivariate 
analysis to understand whether the method has the resolution to identify the differences in the 
mechanism of therapeutic response. Towards achieving the aim, we utilized the mouse xenograft 
model of retinoblastoma and nanoparticle mediated targeted therapy. The results indicate that 
the mechanism underlying the response differed between the treated and untreated group which 
can be elucidated by unique spectral signatures generated by each group. The study establishes 
the efficiency of non-invasive, label-free and rapid FTIR method in assessing the interactions of 
nanoparticles with cellular macromolecules towards monitoring the response to cancer therapeutics.
Over the last few decades, Fourier Transform Infrared ( FTIR) spectroscopy has become a popular spec-
troscopic technique in the field of cancer diagnosis1–3. This has opened a new avenue in the field of 
molecular diagnosis which can effectively identify the presence or absence of specific interaction between 
the biomolecules in the cellular component, qualitatively and quantitatively4. FTIR micro spectroscopy 
is an approach that has advantages over some of the available molecular biological and histopathological 
techniques which rely on statistical confidence and operator expertise5.
The techniques that are routinely used in diagnosing cancer in tissue sections include, immunohis-
tochemistry (IHC), Fluorescent in-situ Hybridization (FISH ) and Chromogenic in situ hybridization 
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(CISH)6. Although, these techniques are extensively used for diagnosis, there is considerable subjectivity 
in the interpretation of the results owing to the inter and intra -observer errors7. The success of the in-situ 
hybridization and immunohistochemical techniques including tissue microarray rely on several physical 
and chemical aspects such as specificity and sensitivity of the probes and antibodies, hybridization/incu-
bation parameters, chemical reagents used for tissue processing, labeling and detection6,7.
In addition, these diagnostic methods do not aid in studying the interaction of different biomolecules 
such as proteins, lipids, nucleic acids in a given sample. For instance, in-situ hybridization is limited to 
studying the nucleic acids while, immunohistochemistry aids in understanding the protein expression. 
Additionally, multiple assays are required to identify multiple protein antigens or nucleic acid targets. 
However, the origin of cancer, its progression and its response to therapy is dependent on the molecular 
interactions occurring between biomolecules (lipids-nucleic acids, protein-lipids; protein-nucleic acid) 
and not on single biomolecule. A technique that has the capacity to assess the cumulative molecular inter-
actions irrespective of the presence or absence of specific target molecule might be more effective. Hence, 
we hypothesized that spectroscopic methods would be helpful in the understanding of the molecular 
interaction with therapeutic molecules. The vibrational spectroscopy relies on the non-perturbing identi-
fication of molecules arising from the inherent chemical composition of the tissue sample8. Spectroscopic 
methods such as FTIR offers a rapid and non-invasive approach of analyzing biomolecules by generating 
distinct and unique spectral signatures derived from various endogenous functional groups present in 
the biomolecules9–11 FTIR is a reagent-free technique with minimal processing and requires less amount 
of sample to analyze the biochemical finger print. In addition, FTIR can also be adapted for clinical 
applications in place of other techniques that use radiations such as X-rays and gamma rays which are 
destructive for the biological samples.
In this study, we explored the utility of Attenuated Total Reflectance Fourier Transform Infrared spec-
troscopy (ATR-FTIR) technique to understand whether the method has the capacity to distinguish the 
mechanism involved in therapeutic response using nanoparticle mediated targeted therapy and retino-
blastoma (RB) xenograft mouse model. Nanoparticle based targeted therapy is preferred for this study for 
the following reasons: (i) Several nanocarrier based approaches have emerged for cancer therapy12–14(ii) 
Almost, all the studies involving nanocarrier based approaches have utilized tumor growth reduction as 
the end point and do not decipher the mechanism of action (iii) None of the studies utilizing nanocarrier 
based approaches have explored the interaction of the nanoparticles with biomolecules to our knowledge; 
(iv) There limited information reported on the utility of ATR-FTIR in studying the interactions of nano-
particles with the biomolecules in cancer therapy13,14.Towards achieving the aim, we generated xenografts 
of retinoblastoma in nude mice and subjected them to treatment with either GNPs-1 (Gold nanoparti-
cles prepared using Vitis vinifera extract, as the reducing agent) functionalized with HDM2 peptide or 
GNPs-2 (Gold nanoparticle prepared using Sodium citrate, as the reducing agent) functionalized with 
HDM2 peptide. The effectiveness of both the GNP conjugates in the tumor reduction was assessed. We 
have applied ATR-FTIR technique to assess the interactions of the GNPs-conjugates with the cellular 
macromolecules such as proteins, lipids, and nucleic acids in the tumor tissue.
The results indicate an interaction of the novel conjugate (GNPs-HDM2) with the tumor, causing a 
change in the chemical composition, which is reflected as a difference in the spectroscopic signatures 
as revealed by the ATR-FTIR method. The study confirms the utility of ATR-FTIR to investigate the 
interaction of the GNPs-HDM2 with cellular component at the molecular level. The study provides a 
‘proof-of-principle’ for evaluating the efficiency of non-invasive, label-free and rapid ATR-FTIR method 
in assessing the interactions of nanoparticles with cellular macromolecules towards establishing the out-
come of cancer therapeutics.
Methods
Generation of retinoblastoma (RB) xenograft model. All the methods were carried out in 
accordance with approved institutional ethical guidelines (institutional ethics study code no: 383-2013-
P; SLAR/ONC/SAN-002). The animal experiment protocols were approved by the “Committee for the 
Purpose of Control and Supervision of Experiments on Animals (CPCSEA)”. For the generation of xeno-
graft, second passage of human RB (Y79) cell line obtained from ATCC, USA at a cell density of 10 × 106 
cells in 200 μ l of serum free media containing 50% of matrigel was subcutaneously injected in the flanks/
back of nude mice (Hsd: Athymic Nude-Foxn1nu). The implanted area was monitored for tumor growth 
daily till the tumor attained palpable size with a tumor volume (TV ≈ 80 mm3). The animals were rand-
omized into 3 groups; control (n = 10), GNPs-1(n = 8) and GNPs-2 (n = 8) (Fig. 1).
Preparation of GNPs-1 and GNPs-2 conjugates and their characterization. The GNPs-1 and 
GNPs-2 were prepared as described previously15,16. The GNPs- anti HDM2 peptide conjugates were 
prepared by mixing varying concentrations of 3-mpa (Mercaptopropionic acid) modified anti-HDM2 
peptide with purified GNPs (GNPS-1 and GNPs-2, separately). The mPEG-thiol stabilized GNPs were 
prepared by mixing 50 μ M (atom of Gold) of GNPs with 1 mg of MPEG-SH-1000. The solution was 
stirred for 12 h followed by removal of un-reacted PEG by centrifugation. The PEG stabilized GNPs 
were mixed with 250 μ M of HDM2 peptide and mixed in a rotary platform for 24 h. The final conju-
gates were subjected to washing and characterized by FTIR and TEM (Supplementary methods). The 
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conjugates were re-suspended in distilled water to obtain a final stock concentration of (50 μ g/ml) for 
further experimentation.
Treatment of RB xenograft models with GNP conjugates. The animals were grouped as control, 
GNPs-1 treated and GNPs-2 treated. The control, GNPs-1 and GNPs-2 animals were subcutaneously 
injected with 100 μ l of sterile water; GNPs-1(50 μ g/ml) and GNPs-2 (50 μ g/ml) respectively. The injection 
site was kept uniform in all the animals in all groups and was made subcutaneously at two sites around 
the tumor. The injection was provided in two-cycles, the first cycle was from 0 till 16 days with a single 
dose per day and the second cycle was from 17th till 24th day with two doses/day. The period of treat-
ment was fixed as 24 days based on the tumor doubling time (approximately 5 days) and the fact that the 
total tumor volume in the control does not exceed 2000 mm3 (for ethical reasons). The tumor growth and 
the body weight of the mice were monitored every three days. The tumor volume was measured with a 
caliper and derived by the formula: Tumor Volume (TV) (mm3) = L × W2/2); where L is the length and 
Figure 1. Treatment of RB xenograft models with GNP conjugates and harvesting of tumors for ATR-
FTIR analysis. A schematic representation of generation of RB xenograft model; the treatment regimen 
using GNP conjugates and harvesting of tissue for ATR-FTIR analysis is provided (A). Representative images 
of Hsd: Athymic Nude-Foxn1nu mice with RB xenograft 24 days post-treatment of control, GNPs-1, GNPs 2 
and their respective tumor harvested for FTIR analysis (B).
www.nature.com/scientificreports/
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W is the width. The relative tumor volume (RTV) was calculated for each group using the formula: TVn/
TV0 where TVn is the tumor volume on a given day and TV0 is the volume on day 0. The mean ± SEM 
were calculated for all the groups and Two way ANOVA was used for calculating statistical significance. 
The tumor growth inhibition (TGI) was calculated using the formula: (1 − T/C) × 100 (where T is the 
mean TV of the test group on day n – mean TV of the test group on day 0 and C is the mean TV of the 
control on day n – mean TV of the control group on day 0). Two way ANOVA was used for calculation 
of statistical significance and p < 0.05 was considered as significant. After completion of the experiment 
period, the animals were sacrificed and tumors were collected (Fig. 1). The subcutaneous tumor tissue 
was snap frozen for further analysis. The dose tolerance of the conjugates was assessed by monitoring 
body weight, biochemical analysis for liver function (alanine aminotransferase (ALT) and aspartate ami-
notransferase (AST)), kidney function (Blood urea nitrogen(BUN) and Creatinine), differential leucocyte 
counts (DLC) and histopathological analysis of vital organs. The tissue was utilized for real- time PCR, 
apoptosis array analysis (Supplementary methods) and FTIR analysis.
Processing of Rb xenografts for FTIR analysis. Three tumor samples were randomly selected from 
each group. The representative mice and tumor from each group has been shown in the Fig. 1. Cryoblocks 
were prepared for the sectioning and cryo-sections of 7 μ m were taken onto the IR-transparent calcium 
fluoride (CaF2) circular window (0.5 mm thickness by 13 mm diameter, Crystan Ltd, Dorset, UK). All 
tissue sections were dried in a dry cabinet before FTIR spectral data collection.
Focal Plane Array (FPA) microspectroscopic imaging using ATR-FTIR. The FPA-FTIR study of 
the RB xenograft tumor samples was performed to identify the difference between the samples. FPA-FTIR 
micro-spectroscopic images were recorded using a Cary 620 FTIR microscope using cooled liquid-N2 
environment with 128 × 128 element FPA detector objective lens, 15 × (0.62 NA) attached with FTIR 
spectrometer (Cary 670 FTIR spectrometer, Agilent Technologies). The FTIR Spectra were collected in 
a transmission mode in the spectral range between 3800-900 cm−1. A single FTIR image was acquired 
in an area of 700 × 700 cm2. A single FTIR spectral image contain the array of 64 × 64 spectra obtained 
from binning of the signal captured on detectors from each square of 4 on FPA array consist of 128 × 128 
elements. A resultant single spectrum of sample collected in FTIR image acquired on ca. 10.9 × 10.9 mm2 
revealed the molecular information about the sample functional group. From each tumor sample 5 FTIR 
spectral images were obtained with a resolution of 4-cm−1 with 128 co-added scans, Blackman-Harris 
3-Term apodization, Power-Spectrum phase correction and a zero-filling factor of 2 using Resolutions 
Pro software package (Agilent Technologies). Before each sample measurement, background measure-
ments were performed using a clean surface of the substrate with the same acquisition parameters17.
Data processing (Statistical Analysis) by Hierarchial clustering analysis (HCA) and Principal 
component analysis (PCA) analysis. The protocol for the multivariate analysis of the FTIR data is 
shown in Flow chart (Supplementary Fig S1). The multivariate data analysis was performed using HCA 
CytoSpec v. 1.4.02 (Cytospec Inc., Boston, MA, USA) and PCA using Unscrambler X 10.1 software pack-
age (CAMO Sofware AS, Oslo, Norway)18. The quality control test was carried out to adjust the signal to 
noise ratio. Biobands were selected over spectral wavelengths covering 1800-930 and 3040-2810 cm−1 19.
The specific spectral range was chosen to get optimal information for a range of biomolecules includ-
ing lipid, protein and nucleic acids as reported previously20,21. The spectral data providing absorbance 
between 0.2–0.8 was used for further analysis.
The second (2nd) derivative was performed by a 9-point Savitzky–Golay algorithm which removed the 
broad baseline offset and curvature22. HCA analysis was carried out with Ward’s algorithm and cluster 
(dendrogram) imaging was carried out with second derivative spectra by randomly assigning five as 
the number of clusters to be generated. In addition, the final spectra were further analyzed by extended 
multiplicative scatter correction (EMSC). This eliminates the physical information collected from the 
scattering of light and removed artefacts introduced during the normalization of the path length differ-
ences. This ensured that the spectra was obtained only from the chemical information (from functional 
group of the biomolecules). The EMSC corrected data is a robust representation of the biomolecules23. 
After EMSC correction, the PCA was performed.
Results
Characterization of GNP conjugates by FTIR and Transmission electron microscopy (TEM). 
The GNPs-1 and GNPs-2 conjugates were characterized by FTIR and TEM. The FTIR spectra were similar 
between both the conjugates and revealed six significant peaks (Supplementary Fig. S2A). The broad IR 
band centered at 3482 cm−1 is attributed to phenolic O-H stretch H-bonded. The bands at 2914 cm−1 and 
2904 cm−1 are attributed to the C-H stretch of the methylene groups of 3 mercaptopropionic acid (MPA) 
attached to the HDM2 peptide24. The similarity in these peaks indicates that the MPA-functionalized 
HDM2 peptide is covalently bound with GNPs. The strong asymmetric band at 1645 cm−1signifies the 
carbonyl stretching of the peptide in the GNPs-1 and GNPs-2 conjugates. The series of bands between 
1500 and 1200 cm−1 are due to the asymmetric and symmetric stretching and bending modes of aliphatic 
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and aromatic amino acids present in the HDM2 peptide sequence (QETFSDLWKLLP). The FTIR data 
provides good evidence that the HDM2 peptide is conjugated with the GNPs.
The GNPs- 1 and GNPs-2 internalization was visualized using TEM after 24 h of culture in the Y79 
cells to confirm the morphology, size of the particles (range of 15–20 nm) and their stability inside the 
cells (Supplementary Fig. S2B). TEM was carried out to characterize the conjugates inside the cells and 
not as conjugates themselves, as it is important to consider the stability of the GNPs inside the cellu-
lar environment25. This is because, the peptide coating changes the basic physiochemical interaction of 
GNPs by the dynamic interfaces between the nanoparticles and the biomolecules inside the cell which 
could affect the internalization of nanoparticles and consequently change the cellular responses. The 
characterization results by FTIR and TEM confirm that the HDM2 peptide is conjugated to the nano-
particles and is stable in a cellular environment (Supplementary Fig S2).
Effect of GNP1 and GNP2 conjugates on the xenograft model. All the mice in the control and 
the treated groups survived until the end of the analysis. The mean body weight of the control, GNP1 
and GNP2 treated groups at the beginning of the treatment (Day 0) were 19.82 ± 0.48, 21.06 ± 0.81 and 
20.33 ± 0.46, respectively. No significant differences in the body weight were observed between the con-
trol and different treatment groups throughout the experiment (p = 0.9988; Two way ANOVA) (Fig. 2C). 
Analysis of the liver function (ALT, AST) and kidney function (Creatinine, BUN) tests revealed that the 
GNP conjugates were non- toxic to the vital organs (Supplementary Fig S3 A-D). The histopathological 
analysis of liver, lung, spleen, heart and kidney in all the groups appeared normal, substantiating the dose 
tolerance and non-toxic nature of the treatments (Supplementary Fig S4). The DLC revealed no signif-
icant changes in the percentage of eosinophils, monocytes, lymphocytes and neutrophils compared to 
the controls suggesting the absence of bone marrow suppression (Supplementary Fig S3E). The analysis 
of the relative tumor volume and tumor growth inhibition revealed that both the GNPs-1 and GNPs-2 
treatment led to a statistically significant difference in the tumor reduction compared to the control 
(p < 0.0001; Two-way ANOVA) (Fig. 2A,B). The tumor growth inhibition at the end of 24 days were 18% 
and 28% in the GNPs-1 and GNPs-2 (p < 0.001) treated groups, respectively.
Hierarchical clustering analysis of the FTIR results. The cluster analysis was performed on 
pre-processed “2nd derivative” data of the area-normalized spectra in the region 3040-930 cm−1. The 
spectral range of 1800-930 and 3040-2810 cm−1 was obtained after vector normalization (Fig.  3A). 
Discrimination between the three samples in a hierarchical tree was made with multi-dimensional HCA 
using Ward’s algorithm, which is the most appropriate method for quantitative variables and clustering 
into group26. The HCA analysis allows for the visualization of the group and sub-group arrangement of the 
spectra. The HCA revealed the intragroup similarity within untreated control GNPs-1 and GNPs-2 groups 
and generated-5 random clusters in each group (Fig. 3C). The difference/similarity is set arbitrarily to 5 
different spectra which are hypothesized to arise from five different kinds of cells of the cancer tissue due 
to its heterogeneous nature (Fig. 3B). These spectra were then kept constant between the samples analyzed.
The difference in the spectral range was established by considering similar areas of biological func-
tional groups in all the samples with the highest possible difference between same tumor samples. The 
dendrograms clearly showed distinct clusters in the control, GNPs-1 and GNPs-2 treated RB xenograft 
tumor sample (Fig. 3C). The results suggested that the biochemical composition of RB xenograft tumor 
sample was differently influenced by the treatment of the two GNP-1 and GNPs-2 compared to the 
control group. While, the HCA dendrogram indicates differences in the treated (GNPs-1 and GNPs-2) 
and untreated groups, there are important questions that are left unanswered for example What are the 
variations in the biochemical functional group between the controls and treated that brings about the 
difference in the HCA analysis? Also how do vibrations of different functional groups in biomolecules 
vary in terms of their intensity and shift? These questions need to be considered for the sensitivity and 
specify the measurement of the FTIR data. Therefore, PCA was used further to get an insight into the 
above mentioned questions.
Principle Component Analysis (PCA). PCA was performed to extract the most significant differ-
ence in the spectra generated between the three groups (control, GNPs-1 and GNPs-2). PCA was per-
formed on the absorbance spectra of the data sets obtained from all the three groups before and after 2nd  
derivatization.
PCA analysis in bio-band range before 2nd derivatization. A total of 1493 raw spectra were 
obtained between wavelengths (3040-930 cm−1) from all three groups (Fig.  4A). This included 543 from 
vehicle control, 486 from GNPs-1 and 464 from GNPs-2. This data was further analyzed in the bioband 
range (1800-930 and 3040-2810 cm−1) (Fig. 4B) followed by the EMSC correction (Fig. 4C) and PCA anal-
ysis on the raw data (Fig.  4D,E). PCA was performed on the spectral data of “BioBands” through cross 
validation at 7 PCs. The interval of the wavelength was kept at 1–60 and 320–548 in the ranges of wave 
numbers: 3040-2810 cm−1 and 1800-930 cm−1, respectively. The actual bioband wave number was 3039.234 
- 2811.677 and 1808.883 - 929.51 cm−1. The specific range was selected since, it is indicated in the identi-
fication of lipids, nucleic acid and protein molecules present in the mammalian cell27,28.PCA was applied 
to all the data and provided 3 levels with 95.22% of variance, best observed in three-dimensional space 
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(PC1 versus PC2 versus PC3) (Fig. 4D,E). The PC score plot of unpriced original data showed clear scat-
tering at different PC levels for all the three groups studied.
Since, there was a higher number of spectral band overlap in the unprocessed spectrum, it was nec-
essary to process the data and use the second derivative to get the distinct individual bands from the 
original data set. Hence, for the optimal analysis, the raw data was subjected to 2nd derivatization.
PCA analysis in bio-band range using data obtained after 2nd derivatization. In the 
pre-processed data before 2nd derivative, an overlap of the vibrations of cellular biomolecules is expected 
and the result derived may reflect the average biochemical information. Second (2nd) derivatization was 
performed with 13-point smoothing and 3 polynomial order (Fig. 5A) to get the sub-band which may 
have been contributed as an average band in the raw data set. The EMSC correction (Fig. 5B) was applied 
to the 2nd derivatization data before PCA analysis. The cumulative variance and score plots (Fig. 5C,D) 
aid in the visualization of the data in PCA, whereas; the loading plot (Fig.  5E) is an indicator of the 
biochemical functional group obtained at PC level29. The PC loading reveals the differences derived 
Figure 2. Effect of GNP conjugates on the xenograft model. The control, GNPs-1 and GNPs-2 mice were 
monitored every three days till 24th day for tumor growth (tumor volume measured using caliper) and body 
weight. The relative tumor volume (RTV) and tumor growth inhibition were calculated. Mean ± SEM was 
calculated for the RTV data and tumor growth inhibition was presented as a percentage. Two way ANOVA 
was utilized for statistical analysis and p value < 0.05 was considered significant. RTV (A) and TGI (B) 
showed statistically significant difference between the control and the treated groups (p < 0.0001). Analysis 
of the body weight in grams revealed that the body weight of the mice did not significantly differ between 
different groups throughout the treatment (p = 0.0938; Two way ANOVA) (C).
www.nature.com/scientificreports/
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from unique signatures pertaining to the vibration of various biomolecules which are a source of varia-
tion between samples (Fig. 5E). PCA analysis revealed a clear discrimination between the three groups, 
which is a function of the PC variation in the samples. It was observed that at PC-1 (GNPs-2) and PC-3 
(GNPs-1) more loading was observed with respect to the control (Fig. 5E). These differences are proba-
bly due to the differences in the treatment of GNPs-1 and GNPs-2. We attempted to interpret each PC 
loading in terms of the difference in positivity and negativity loading of the functional group (Table 1). 
Figure 3. Hierarchial clustering analysis (HCA) of the FTIR data. FPA-FTIR microspectroscopic images 
of the tumors obtained from each group (Control, GNPs-1 and GNPs-2 ) were subjected to quality test 
and signal to noise (S/N) reduction followed by 2nd derivatization and vector normalization. HCA map 
was generated from the pre-processed 2ndderivative data (A). HCA dendrogram was obtained by Ward’s 
algorithm and squared Euclidean distance measure criterion, using the entire dataset that included the five 
clusters in each samples. The average spectrum (B) and the dendrogram (C) for the Control, GNPs-1 and 
GNPs-2 are provided. The Y axis denotes the relative distance and X axis denotes the 5 different clusters 
corresponding to the spectra which are hypothesized to arise from five different kinds of cells in the tumor 
tissue.
www.nature.com/scientificreports/
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The difference in the PC corresponding to GNPs-1 (PC3) and GNPs-2 (PC1) could be attributed to the 
different chemical used for synthesis of GNPs (Fig. 5E). The extent of PC loading (both positive and neg-
ative) was highest in the PC3 corresponding to GNPs-1 and lowest in PC1 corresponding to GNPs-2 in 
the bioband range 1800-930 cm−1 (actual range: 1808.883-929.511 cm−1)whereas the extent of PC loading 
was more in PC2 corresponding to control compared to GNPs-1 and GNPs-2 in the bioband range 3040-
2810 cm−1 (actual range: 3039.234-2811.677 cm−1) (Fig. 5E).
The PC-3 corresponding to GNPs-1 showed the highest number of loading both positive and neg-
ative compared to GNPs-2 and control (Table 1). The GNPs-1 is reduced with the Vitis vinifera which 
consists of polyphenols and hence resulted in higher biochemical changes in a wide range of the macro-
molecules such as lipids, protein, and nucleic acid. Alternatively, GNPs-2 synthesized with the sodium 
Figure 4. Principal component analysis (PCA) on the raw spectral data before 2nd derivatization. The 
raw spectral data (wavelength range 3040-930 cm−1) (A) was pre-processed to obtain the “bioband” spectra 
(wavelength: 1800-930 cm−1; 3040-2810 cm−1) corresponding to the major biomolecules such as proteins, 
lipids and nucleic acids (B). The spectra corresponding to bioband range was further analyzed by extended 
multiplicative scatter correction (EMSC) to obtain only the spectra from chemical information (C). PCA 
analysis of the EMSC corrected spectra revealed maximum difference in the PCs between the Control, 
GNPs-1 and GNPs-2 as revealed by the Cumulative variance plot (D) and PCA score plot (E).
www.nature.com/scientificreports/
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citrate showed interaction mostly with the lipid molecules and could justify the reduction in loading as 
observed in PC-1 (Fig. 5E).
The difference in the loading observed between the groups could be correlated to the biological 
responses such as difference in tumour growth reduction (as explained above, Fig. 2); and the mecha-
nism underlying the response to treatment. The real-time PCR and apoptotic array analysis were carried 
out to find the mechanism behind the responses to the different treatments. The real time PCR anal-
ysis of the control, GNPs-1 and GNPs-2 groups revealed that the transcript levels of p53 was signifi-
cantly upregulated in the GNPs-1 while significantly down-regulated in the GNPs-2 group compared to 
Figure 5. Principal component analysis (PCA) on the 2nd derivative spectra. The 2nd derivative spectra 
(A) was analyzed by EMSC to obtain the spectra from chemical information (B). The cumulative variance 
plot (C) and the PCA score plot (D) revealed maximum variance between the three groups control (PC2), 
GNPs-1(PC3) and GNPs-2 (PC1). The PCA loading plot showed maximum difference in the bioband range 
between the three groups (E). The graph summarizing the biomolecules in both positive and loading with 
respect to all the three PC level is provided (F).
www.nature.com/scientificreports/
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Level of PC Loadings Wavelength (cm−1)
PC-1 (+)  1092 -PO2− group of DNA/RNA and phospholipids backbone
 1242- β -sheet of amide III bond
 1622- Antiparallel β -sheet, V(C = O) of carboxylate and V(C = C) of aromatic compounds of amide I bond
 1738- V(C = O) bond of esters group from fatty acids and lipid triglycerides
 2847- Vs(C–H) bond of methylene (–CH2) of lipids
 2929- Vas(C–H) bond of methylene (–CH2) of lipids
PC-1 (−)  1758- V(C = O) bond of esters group from fatty acids and lipid triglycerides
 1649- V(C = C) of di substituted cis-olefins and α -helix of amide I
 1388- δs(CH3) and ds(CH2) of lipids and proteins
PC-2 (+)  1377- δs(CH3) from cholesterol and fatty acid radicals 
 1441- V(C–N) of the pyridine ring 
 1526- Parallel mode of the α -helix of amide II
 1625- Antiparallel b-sheet of amide I, V(C = O) of carboxylate and V(C = C) of aromatic compounds
 2851- Vs(C–H) from methylene (–CH2) groups of lipids
 2937- Vas(C–H) from methylene (–CH2) groups of lipids
PC-2 (−)  1675- β -turn of amide I
 1150- Vas(CO–O–C) group of glycogen and nucleic acids (DNA and RNA)
PC-3 (+)  982- γ( = CH) of trans isomers and conjugated trans, vibration involving OH group of ribose rings in RNA
 1029- V(C–C) coupled with δ(CH2) of αCH2 in –CH2OH groups of polysaccharides
 1109- Vs(C–O) at the 2′-OH group of ribose rings in RNA
 1249- β -sheet of amide III
 1342- γwag(CH2) of αCH2 groups in polyethylene chains
 1416-δrock(CH2) of di-substituted cis-olefins
 1468-δscissor(CH2) from methylene (–CH2) groups in acyl chains of lipid bilayers in orthorhombic packing
 1555- α -helix and antiparallel β -sheet of amide II
 1675- β –turn of amide I
 2888- Vs (C–H) from methyl (–CH3) groups of lipids
 2948- Vas(C–H) from methylene (–CH2) groups of lipids
PC-3 (−)  1649- V(C = C) of di-substituted cis-olefins and α -helix of amide I
 1529- Parallel mode of the α -helix in amide II
 1056- Vs (R–O–P–O–R) from ring vibrations of carbohydrates
 1229- -(PO2−) PO2− group of DNA/RNA and phospholipids backbone
Table 1.  Major spectral peaks identified in different treatment groups and their functional group 
assignments17,49,50. Abbreviations: V-Stretching Vibration; Vs–Symmetric Stretching Vibration;  
Vas-Asymmetric Stretching Vibration, δ - in plane bending vibration.
controls (Supplementary Fig S5A). In addition, the transcript levels of HDM2 were found to be signif-
icantly downregulated in both the treated groups compared to control (Supplementary Fig S5B). This 
suggested that the GNPs-1 and GNPs-2 were going through p53 dependent and p53 independent path-
ways, respectively. The apoptotic array analysis on the three groups showed differences in 17 out of 35 
proteins analyzed (Supplementary Fig S5C). The targets of p53 such as FAS30,31, FADD31 and TRAILR232 
were significantly upregulated in GNPs-1 group with a consequent increase in the procaspase 3 and 
cleaved caspase 3 suggesting p53 dependent apoptotic pathway. The phosphorylated p53 levels were not 
www.nature.com/scientificreports/
1 1Scientific RepoRts | 5:16649 | DOI: 10.1038/srep16649
significantly upregulated in these groups. A recent study suggests that phosphorylation of p53 is dispen-
sable for both transcriptional activation and apoptosis33
On the other hand in the GNPs-2, the p53 dependent proteins were not significantly different. In 
addition, Bcl2, a pro-apoptotic protein level was significantly down regulated in the GNPs-2 treated 
group without an increase in the caspases. Recent studies on the inhibition of Bcl2 shows that the sup-
pression of Bcl2 in the absence of caspase dependent apoptosis leads to autophagic cell death in leukemia 
and breast cancer34,35. In addition, HIF 1 alpha was also found to be down regulated in the GNP2 group. 
It has been shown previously that inhibition of HDM2 by nutlin3 an antagonist leads to downregulation 
of HIF 1 alpha even in p53 null cells which eventually leads to VEGF suppression36. Suppression of VEGF 
in retinoblastoma has earlier been shown to inhibit cell tumorigenesis37.
However, in both the treatments, Hsp60 and survivin levels were found to be significantly upregulated 
compared to control, suggesting that the HDM2 peptide may not be effective in controlling this pathway 
that may have reduced the efficacy of the current treatment (Supplementary Fig S5C). Hence, the differ-
ences in the PC loading that were observed with the FTIR data could be attributed to the mechanism 
leading to the therapeutic responses.
After the overall analysis of the PC loadings, the results of the different bands at different PCs level 
were analyzed (Table 1). To set the difference in PC loading the most significant positive and negative 
loadings (both the intensity and shift in the spectral peak) were considered in the treated (GNPs-1 and 
GNPs-2) and untreated (Control) groups. A reduction in the PC loadings between the wavelengths 3400 
to 2800 was observed in GNP-1 compared to the control and GNP- 2 groups. This specific range of wave-
length (3700 to 2800) representative of the lipids is indicated in malignancy19. Hence, the observation of 
reduction in this PC loading indirectly might indicate the response to treatment with regard to the GNP-
1, which might imply the use of this spectral signature as a potential marker in the specific therapeutic 
scenario38. However, the therapeutic response could also be appreciated in GNPs-2 which did not show 
significant PC loading difference in the above-mentioned wavelength compared to the control. There 
was a shift in the wavenumber corresponding to CH2 anti-symmetric and CH2 symmetric stretching of 
lipids in GNP-2 compared to control (Table 1). While the CH2 anti- symmetric stretching was observed 
at wavenumber 2937 cm−1 in case of the control (PC2); a shift towards a lower wavelength 2929 cm−1 and 
increase in intensity was observed in case of GNPs-2 (PC1); it is hypothesized that the spectral shift and 
change in the intensity may reflect the response to the specific treatment with GNPs-2.
Similarly, signal in the wavenumber range 1700 cm−1 to 1600 cm−1; corresponding primarily to the 
proteins amide I functional group were present in all the three groups with a difference in the intensity 
in the order of PC2 > PC3 > PC1. While the amide I functional group was due to the C = O stretching 
of the peptide bond with a secondary conformation of β -sheet in the control (PC2) and GNPs-2 (PC1); 
the same was enriched as β -turn conformation in the GNPs-1 (PC3) group. The analysis of wavelength 
suggested that there was a significant shift in case of GNPs-1 (PC3) (1675) compared to the control 
(PC2) (1625) and GNPs-2 (PC1) (1622). In addition, in the case of the control (PC2), the amide I with 
the secondary structure of β -turn conformation was increased in the negative loading. In addition, the 
functional group corresponding to amide III β -sheet was present in the positive loadings of the treated 
groups GNPs-1 (PC3) and GNPs-2 (PC1) and not in the control (PC2). However, there was a wavelength 
shift which differentiated the different treatments (Table  1). It is hypothesized; that the spectral signa-
ture corresponding to the amide III might serve as a diagnostic marker for monitoring the therapeutic 
response irrespective of the GNPs.
With respect to the phosphate group containing biomolecules such as phospholipids, nucleic acids 
and phosphorylated polysaccharides a significant difference in the positive loading was observed in the 
wavenumber range 1100-800 cm−1 between the treated group (GNPs-1 (PC3) and GNPs-2 (PC1)) com-
pared to the control group (PC2).The decrease in the phosphate group containing molecules are reported 
in cancer tissue as a diagnostic marker39,40. Hence, their enrichment could be attributed to the response 
to the therapy. Together, the results suggest that the amide III β sheet and the phosphate group con-
taining biomolecules might serve the purpose of monitoring the response to functionalized GNP based 
therapies.
Discussion
FTIR spectroscopy is currently being employed as a tool to derive biochemical signatures for a wide range 
of cells and tissues41. FTIR has been used to distinguish the normal and cancer cells due to the presence 
or absence of macromolecules such as nucleic acids, proteins, lipids and carbohydrates and differences in 
their configurations42–44. FTIR has been useful in identifying the differences in complex cancer tissue as 
variations in the spectral profiles contributed by specific vibrational peak shifts, band shapes and inten-
sity. The spectroscopic methodology could be a new diagnostic tool for the analysis of the tumor sample 
due to sensitivity and specificity without interference of chemicals used in the processing of the tissue 
for the analysis unlike IHC where interference can be a problem45. In this study, we explored the possi-
bility of utilizing FTIR in place of the conventional techniques for investigating the therapeutic response 
and mechanisms involved in nanoparticle mediated targeted therapy (GNPs-HDM2) in a RB xenograft 
mouse model. Comparison of the FTIR spectra for PC-1 to PC-3 clearly revealed the difference induced 
by GNPs-2 and GNPs-1. From these results, we can hypothesize that a targeted moiety can interact with 
the different biomolecules during the treatment. As we have noticed here, although a peptide (HDM2) 
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was used for the targeting the oncoprotein molecule, due to difference in the carrier molecules (GNPs) 
the interactions were not limited to the protein and a significant difference was observed in interactions 
with various biomolecules as revealed by the PCs loading (Fig. 5F) compared to the control samples. As 
discussed, GNPs-2 showed loadings predominantly corresponding to lipids, whereas GNPs-1 showed 
significant loadings corresponding to proteins with little or no lipids. The difference in the specific band 
loading is a means to identify the difference of the biomolecules. In a similar study FTIR analysis to dif-
ferentiate between normal and a mutated genome was used to screen the mutagenic potential effect of the 
drug46. The application of FTIR in combination with specific biological assays can be utilized for assign-
ing the differential band position and intensity to specific molecular events between compared samples47.
In addition, most of the research studies widely use molecular biological techniques such as gene 
expression and protein expression studies to analyze the mechanism of action of drugs, peptides or 
siRNA13. For instance, the validation of peptide or siRNA based experiments is limited to protein expres-
sion, while the differences in the other biomolecules are ignored. Since, biological systems are complex, 
modulation of one specific group of biomolecule (e.g. protein) can cause a cascade of changes that does 
not limit itself to target groups such as protein. Hence a method that would provide a holistic view of 
interactions between different biomolecules are vital48. Application of FTIR fulfills the above mentioned 
criteria. Our results reiterate the need for a method like FTIR for understanding the complete array of 
biomolecular interactions. Additionally, the combination of FTIR with multivariate analysis could pro-
vide a non-invasive and reproducible method for assessing the differences between untreated/treated, 
cancerous/non-cancerous samples. The transformation of the tissue states from normal to cancer of 
treated to untreated is attributed to biochemical changes within the tissue. Since the tumor is an abnor-
mal stage of the cell associated with chemical changes at the molecular level, the tumor cells can be 
monitored in comparison with the normal cells based on their chemical composition, thereby giving vital 
information with regard to early diagnosis of the tumor stages, benign or malignant. As an extension, 
the technique has the ability to provide biologically relevant data which could be clinically significant in 
diseases like cancer which are highly heterogeneous; thereby aiding in rationalizing the treatment plan 
and drug designing. Furthermore, FTIR can be applied in vivo/in situ for monitoring the progression of 
cancer and its response to therapy without the requirement for obtaining tissue biopsy for histochemical 
analysis which makes it the preferred method due to its non-invasiveness and rapidity49,50.
Conclusion
The advent of FTIR with multivariate analysis has revolutionized the field of cancer. Conservatively, can-
cer biomarkers or targets are inferred as single or multiple genes, proteins or other biomolecules which 
are identified by specific molecular or integrated “omics” approach. FTIR offers unique advantages as 
it reflects the overall vibrations of the cellular components and their interactions within the samples as 
spectra in addition to being non-invasive and label-free, unlike conventional molecular methods. FTIR 
has been utilized in the field of oncology to distinguish normal and cancerous tissue, and for grading 
cancers which allow for treatment decisions. In this study, we utilized RB xenograft model and nano-
particle based therapy to establish the utility of FTIR. The technique was capable of differentiating the 
mechanistic and therapeutic response in the treated and untreated groups as variations in their spectral 
signatures which corresponds to the differences in their biomolecular fingerprint. In total, the current 
finding expand the potential use of the FTIR- technique in the field of cancer therapeutics primarily 
where the focus is on interactions between a drug (here nanoparticle) and the target molecules. Future 
experiments should include longitudinal studies involving temporal analysis of tumor growth as regres-
sion and/or relapse in the animal models of cancer can aid in the monitoring of therapeutic response 
using FTIR.
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